{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:27:57Z","timestamp":1794652077847,"version":"4.9.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/20\/S\/NZ7\/00424"],"award-info":[{"award-number":["2016\/20\/S\/NZ7\/00424"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The pharmacological activation of the GPR39 receptor has been proposed as a novel strategy for treating seizures; however, this hypothesis has not been verified experimentally. TC-G 1008 is a small molecule agonist increasingly used to study GPR39 receptor function but has not been validated using gene knockout. Our aim was to assess whether TC-G 1008 produces anti-seizure\/anti-epileptogenic effects in vivo\u00a0and whether the effects are mediated by GPR39. To obtain this goal we utilized various animal\u00a0models of seizures\/epileptogenesis and GPR39 knockout mice model. Generally, TC-G 1008 exacerbated behavioral seizures. Furthermore, it increased the mean duration of local field potential recordings in response to pentylenetetrazole (PTZ) in zebrafish larvae. It facilitated the development of epileptogenesis in the PTZ-induced kindling model of epilepsy in mice. We demonstrated that TC-G 1008 aggravated PTZ-epileptogenesis by selectively acting at GPR39. However, a concomitant analysis of the downstream effects on the cyclic-AMP-response element binding protein in the hippocampus of GPR39 knockout mice suggested that the molecule also acts via other targets. Our data argue against GPR39 activation being a viable therapeutic strategy for treating epilepsy and suggest investigating whether TC-G 1008 is a selective agonist of the GPR39 receptor.<\/jats:p>","DOI":"10.1007\/s00018-023-04766-z","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T15:02:36Z","timestamp":1682434956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["TC-G 1008 facilitates epileptogenesis by acting selectively at the GPR39 receptor but non-selectively activates CREB in the hippocampus of pentylenetetrazole-kindled mice"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2700-8155","authenticated-orcid":false,"given":"Urszula","family":"Doboszewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7706-2080","authenticated-orcid":false,"given":"Katarzyna","family":"Soca\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8772-3225","authenticated-orcid":false,"given":"Mateusz","family":"Pier\u00f3g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9446-7343","authenticated-orcid":false,"given":"Dorota","family":"Nieoczym","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5945-1047","authenticated-orcid":false,"given":"Jan","family":"Sawicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8619-5659","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Szafarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8857-847X","authenticated-orcid":false,"given":"Kinga","family":"Gawel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7576-8039","authenticated-orcid":false,"given":"Anna","family":"Rafa\u0142o-Uli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7385-2875","authenticated-orcid":false,"given":"Adam","family":"Sajn\u00f3g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4798-0574","authenticated-orcid":false,"given":"El\u017cbieta","family":"Wyska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2271-8094","authenticated-orcid":false,"given":"Camila V.","family":"Esguerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6863-7951","authenticated-orcid":false,"given":"Bernadeta","family":"Szewczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6056-9595","authenticated-orcid":false,"given":"Marzena","family":"Ma\u0107kowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1186-3552","authenticated-orcid":false,"given":"Danuta","family":"Bara\u0142kiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9257-8154","authenticated-orcid":false,"given":"Katarzyna","family":"Mlyniec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3000-7938","authenticated-orcid":false,"given":"Gabriel","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9346-6325","authenticated-orcid":false,"given":"Ireneusz","family":"Sowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-0241","authenticated-orcid":false,"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"4766_CR1","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3390\/ijms18112285","volume":"18","author":"W Maret","year":"2017","unstructured":"Maret W (2017) Zinc in cellular regulation: the nature and significance of \u201czinc signals.\u201d Int J Mol Sci 18:2285","journal-title":"Int J Mol Sci"},{"key":"4766_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.pharmthera.2018.08.013","volume":"193","author":"U Doboszewska","year":"2019","unstructured":"Doboszewska U, M\u0142yniec K, Wla\u017a A, Poleszak E, Nowak G, Wla\u017a P (2019) Zinc signaling and epilepsy. Pharmacol Ther 193:156\u2013177","journal-title":"Pharmacol Ther"},{"key":"4766_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/10799890701506147","volume":"27","author":"S Yasuda","year":"2007","unstructured":"Yasuda S, Miyazaki T, Munechika K, Yamashita M, Ikeda Y, Kamizono A (2007) Isolation of Zn2+ as an endogenous agonist of GPR39 from fetal bovine serum. J Recept Signal Transduct Res 27:235\u2013246","journal-title":"J Recept Signal Transduct Res"},{"key":"4766_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1210\/en.2006-0933","volume":"148","author":"B Holst","year":"2007","unstructured":"Holst B, Egerod KL, Schild E, Vickers SP, Cheetham S, Gerlach LO, Storjohann L, Stidsen CE, Jones R, Beck-Sickinger AG, Schwartz TW (2007) GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 148:13\u201320","journal-title":"Endocrinology"},{"key":"4766_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1006\/geno.1997.5069","volume":"46","author":"KK McKee","year":"1997","unstructured":"McKee KK, Tan CP, Palyha OC, Liu J, Feighner SD, Hreniuk DL, Smith RG, Howard AD, Van der Ploeg LH (1997) Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. Genomics 46:426\u2013434","journal-title":"Genomics"},{"key":"4766_CR6","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1126\/science.1117255","volume":"310","author":"JV Zhang","year":"2005","unstructured":"Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin\u2019s effects on food intake. Science 310:996\u2013999","journal-title":"Science"},{"key":"4766_CR7","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1126\/science.1135047","volume":"315","author":"N Chartrel","year":"2007","unstructured":"Chartrel N, Alvear-Perez R, Leprince J, Iturrioz X, Reaux-Le GA, Audinot V, Chomarat P, Coge F, Nosjean O, Rodriguez M, Galizzi JP, Boutin JA, Vaudry H, Llorens-Cortes C (2007) Comment on \u201cObestatin, a peptide encoded by the ghrelin gene, opposes ghrelin\u2019s effects on food intake.\u201d Science 315:766","journal-title":"Science"},{"key":"4766_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbrc.2006.09.141","volume":"351","author":"E Lauwers","year":"2006","unstructured":"Lauwers E, Landuyt B, Arckens L, Schoofs L, Luyten W (2006) Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun 351:21\u201325","journal-title":"Biochem Biophys Res Commun"},{"key":"4766_CR9","doi-asserted-by":"publisher","first-page":"11749","DOI":"10.1073\/pnas.201193398","volume":"98","author":"M Hershfinkel","year":"2001","unstructured":"Hershfinkel M, Moran A, Grossman N, Sekler I (2001) A zinc-sensing receptor triggers the release of intracellular Ca2+ and regulates ion transport. Proc Natl Acad Sci USA 98:11749\u201311754","journal-title":"Proc Natl Acad Sci USA"},{"key":"4766_CR10","doi-asserted-by":"publisher","first-page":"12325","DOI":"10.1073\/pnas.231481398","volume":"98","author":"W Maret","year":"2001","unstructured":"Maret W (2001) Crosstalk of the group IIa and IIb metals calcium and zinc in cellular signaling. Proc Natl Acad Sci USA 98:12325\u201312327","journal-title":"Proc Natl Acad Sci USA"},{"key":"4766_CR11","doi-asserted-by":"publisher","first-page":"C1011","DOI":"10.1152\/ajpcell.00454.2021","volume":"322","author":"NJ Alkayed","year":"2022","unstructured":"Alkayed NJ, Cao Z, Qian ZY, Nagarajan S, Liu X, Nelson JW, Xie F, Li B, Fan W, Liu L, Grafe MR, Davis CM, Xiao X, Barnes AP, Kaul S (2022) Control of coronary vascular resistance by eicosanoids via a novel GPCR. Am J Physiol Cell Physiol 322:C1011\u2013C1021","journal-title":"Am J Physiol Cell Physiol"},{"key":"4766_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd.2017.178","volume":"16","author":"AS Hauser","year":"2017","unstructured":"Hauser AS, Attwood MM, Rask-Andersen M, Schioth HB, Gloriam DE (2017) Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov 16:829\u2013842","journal-title":"Nat Rev Drug Discov"},{"key":"4766_CR13","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1182\/blood.2021013950","volume":"139","author":"L Iovino","year":"2022","unstructured":"Iovino L, Cooper K, deRoos P, Kinsella S, Evandy C, Ugrai T, Mazziotta F, Ensbey KS, Granadier D, Hopwo K, Smith C, Gagnon A, Galimberti S, Petrini M, Hill GR, Dudakov JA (2022) Activation of the zinc-sensing receptor GPR39 promotes T-cell reconstitution after hematopoietic cell transplant in mice. Blood 139:3655\u20133666","journal-title":"Blood"},{"key":"4766_CR14","doi-asserted-by":"publisher","first-page":"H1030","DOI":"10.1152\/ajpheart.00312.2021","volume":"321","author":"C Methner","year":"2021","unstructured":"Methner C, Cao Z, Mishra A, Kaul S (2021) Mechanism and potential treatment of the \u201cno reflow\u201d phenomenon after acute myocardial infarction: role of pericytes and GPR39. Am J Physiol Heart Circ Physiol 321:H1030\u2013H1041","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4766_CR15","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/cbin.11566","volume":"45","author":"H Liao","year":"2021","unstructured":"Liao H, Gao W, Ma J, Xue H, Wang Y, Huang D, Yan F, Ye Y (2021) GPR39 promotes cardiac hypertrophy by regulating the AMPK-mTOR pathway and protein synthesis. Cell Biol Int 45:1211\u20131219","journal-title":"Cell Biol Int"},{"key":"4766_CR16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2208541120","volume":"120","author":"SP Meda Venkata","year":"2023","unstructured":"Meda Venkata SP, Li H, Xu L, Koh JY, Nguyen H, Minjares M, Li C, Kowluru A, Milligan G, Wang JM (2023) Inhibition of GPR39 restores defects in endothelial cell-mediated neovascularization under the duress of chronic hyperglycemia: evidence for regulatory roles of the sonic hedgehog signaling axis. Proc Natl Acad Sci USA 120:e2208541120","journal-title":"Proc Natl Acad Sci USA"},{"key":"4766_CR17","volume":"7","author":"CM Davis","year":"2021","unstructured":"Davis CM, Bah TM, Zhang WH, Nelson JW, Golgotiu K, Nie X, Alkayed FN, Young JM, Woltjer RL, Silbert LC, Grafe MR, Alkayed NJ (2021) GPR39 localization in the aging human brain and correlation of expression and polymorphism with vascular cognitive impairment. Alzheimers Dement 7:e12214","journal-title":"Alzheimers Dement"},{"key":"4766_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108752","volume":"198","author":"A Sah","year":"2021","unstructured":"Sah A, Kharitonova M, M\u0142yniec K (2021) Neuronal correlates underlying the role of the zinc sensing receptor (GPR39) in passive-coping behaviour. Neuropharmacology 198:108752","journal-title":"Neuropharmacology"},{"key":"4766_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-021-02289-7","volume":"18","author":"S Xie","year":"2021","unstructured":"Xie S, Jiang X, Doycheva DM, Shi H, Jin P, Gao L, Liu R, Xiao J, Hu X, Tang J, Zhang L, Zhang JH (2021) Activation of GPR39 with TC-G 1008 attenuates neuroinflammation via SIRT1\/PGC-1a\/Nrf2 pathway post-neonatal hypoxic-ischemic injury in rats. J Neuroinflammation 18:226","journal-title":"J Neuroinflammation"},{"key":"4766_CR20","doi-asserted-by":"publisher","first-page":"12916","DOI":"10.1523\/JNEUROSCI.2205-11.2011","volume":"31","author":"E Chorin","year":"2011","unstructured":"Chorin E, Vinograd O, Fleidervish I, Gilad D, Herrmann S, Sekler I, Aizenman E, Hershfinkel M (2011) Upregulation of KCC2 activity by zinc-mediated neurotransmission via the mZnR\/GPR39 receptor. J Neurosci 31:12916\u201312926","journal-title":"J Neurosci"},{"key":"4766_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.nbd.2014.12.020","volume":"81","author":"D Gilad","year":"2015","unstructured":"Gilad D, Shorer S, Ketzef M, Friedman A, Sekler I, Aizenman E, Hershfinkel M (2015) Homeostatic regulation of KCC2 activity by the zinc receptor mZnR\/GPR39 during seizures. Neurobiol Dis 81:4\u201313","journal-title":"Neurobiol Dis"},{"key":"4766_CR22","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3389\/fnins.2019.00920","volume":"13","author":"NN Chen","year":"2019","unstructured":"Chen NN, Zhao DJ, Sun YX, Wang DD, Ni H (2019) Long-term effects of zinc deficiency and zinc supplementation on developmental seizure-induced brain damage and the underlying GPR39\/ZnT-3 and MBP expression in the hippocampus. Front Neurosci 13:920","journal-title":"Front Neurosci"},{"key":"4766_CR23","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3390\/cells9051285","volume":"9","author":"I Wasilewska","year":"2020","unstructured":"Wasilewska I, Gupta RK, Wojtas B, Palchevska O, Ku\u017anicki J (2020) stim2b knockout induces hyperactivity and susceptibility to seizures in zebrafish larvae. Cells 9:1285","journal-title":"Cells"},{"key":"4766_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.biopha.2016.02.026","volume":"79","author":"MZ Khan","year":"2016","unstructured":"Khan MZ (2016) A possible significant role of zinc and GPR39 zinc sensing receptor in Alzheimer disease and epilepsy. Biomed Pharmacother 79:263\u2013272","journal-title":"Biomed Pharmacother"},{"key":"4766_CR25","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1528-1167.2011.03391.x","volume":"53","author":"AS Galanopoulou","year":"2012","unstructured":"Galanopoulou AS, Buckmaster PS, Staley KJ, Moshe SL, Perucca E, Engel J Jr, L\u00f6scher W, Noebels JL, Pitk\u00e4nen A, Stables J, White HS, O\u2019Brien TJ, Simonato M (2012) Identification of new epilepsy treatments: issues in preclinical methodology. Epilepsia 53:571\u2013582","journal-title":"Epilepsia"},{"key":"4766_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.pharmthera.2019.05.006","volume":"200","author":"M Seyedabadi","year":"2019","unstructured":"Seyedabadi M, Ghahremani MH, Albert PR (2019) Biased signaling of G protein coupled receptors (GPCRs): molecular determinants of GPCR\/transducer selectivity and therapeutic potential. Pharmacol Ther 200:148\u2013178","journal-title":"Pharmacol Ther"},{"key":"4766_CR27","doi-asserted-by":"publisher","first-page":"53806","DOI":"10.1074\/jbc.M407676200","volume":"279","author":"B Holst","year":"2004","unstructured":"Holst B, Holliday ND, Bach A, Elling CE, Cox HM, Schwartz TW (2004) Common structural basis for constitutive activity of the ghrelin receptor family. J Biol Chem 279:53806\u201353817","journal-title":"J Biol Chem"},{"key":"4766_CR28","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1021\/ml500240d","volume":"5","author":"S Peukert","year":"2014","unstructured":"Peukert S, Hughes R, Nunez J, He G, Yan Z, Jain R, Llamas L, Luchansky S, Carlson A, Liang G, Kunjathoor V, Pietropaolo M, Shapiro J, Castellana A, Wu X, Bose A (2014) Discovery of 2-pyridylpyrimidines as the first orally bioavailable GPR39 agonists. ACS Med Chem Lett 5:1114\u20131118","journal-title":"ACS Med Chem Lett"},{"key":"4766_CR29","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1124\/mol.116.106112","volume":"90","author":"S Sato","year":"2016","unstructured":"Sato S, Huang XP, Kroeze WK, Roth BL (2016) Discovery and characterization of novel GPR39 agonists allosterically modulated by zinc. Mol Pharmacol 90:726\u2013737","journal-title":"Mol Pharmacol"},{"key":"4766_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bcp.2017.06.115","volume":"140","author":"Y Shimizu","year":"2017","unstructured":"Shimizu Y, Koyama R, Kawamoto T (2017) Rho kinase-dependent desensitization of GPR39; a unique mechanism of GPCR downregulation. Biochem Pharmacol 140:105\u2013114","journal-title":"Biochem Pharmacol"},{"key":"4766_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107872","volume":"227","author":"K Sa\u0142aciak","year":"2021","unstructured":"Sa\u0142aciak K, Pytka K (2021) Biased agonism in drug discovery: is there a future for biased 5-HT1A receptor agonists in the treatment of neuropsychiatric diseases? Pharmacol Ther 227:107872","journal-title":"Pharmacol Ther"},{"key":"4766_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0165-6147(00)01996-9","volume":"23","author":"S Tucek","year":"2002","unstructured":"Tucek S, Michal P, Vlachova V (2002) Modelling the consequences of receptor-G-protein promiscuity. Trends Pharmacol Sci 23:171\u2013176","journal-title":"Trends Pharmacol Sci"},{"key":"4766_CR33","doi-asserted-by":"publisher","first-page":"6869","DOI":"10.1007\/s12035-015-9586-3","volume":"53","author":"G Sata\u0142a","year":"2016","unstructured":"Sata\u0142a G, Duszy\u0144ska B, Stachowicz K, Rafalo A, Pochwat B, Luckhart C, Albert PR, Daigle M, Tanaka KF, Hen R, Lenda T, Nowak G, Bojarski AJ, Szewczyk B (2016) Concentration-dependent dual mode of Zn action at serotonin 5-HT1A receptors: in vitro and in vivo studies. Mol Neurobiol 53:6869\u20136881","journal-title":"Mol Neurobiol"},{"key":"4766_CR34","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.3390\/ijms22083872","volume":"22","author":"A Laitakari","year":"2021","unstructured":"Laitakari A, Liu L, Frimurer TM, Holst B (2021) The zinc-sensing receptor GPR39 in physiology and as a pharmacological target. Int J Mol Sci 22:3872","journal-title":"Int J Mol Sci"},{"key":"4766_CR35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/epi4.12580","volume":"7","author":"J Sourbron","year":"2022","unstructured":"Sourbron J, Lagae L (2022) Serotonin receptors in epilepsy: novel treatment targets? Epilepsia Open 7:231\u2013246","journal-title":"Epilepsia Open"},{"key":"4766_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00221-013-3757-0","volume":"232","author":"MH Gharedaghi","year":"2014","unstructured":"Gharedaghi MH, Seyedabadi M, Ghia JE, Dehpour AR, Rahimian R (2014) The role of different serotonin receptor subtypes in seizure susceptibility. Exp Brain Res 232:347\u2013367","journal-title":"Exp Brain Res"},{"key":"4766_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-1-0716-1254-5_5","volume-title":"Experimental and translational methods to screen drugs effective against seizures and epilepsy","author":"K Soca\u0142a","year":"2021","unstructured":"Soca\u0142a K, Wla\u017a P (2021) Acute seizure tests used in epilepsy research: step-by-step protocol of the maximal electroshock seizure (MES) test, the maximal electroshock seizure threshold (MEST) test, and the pentylenetetrazole (PTZ)-induced seizure test in rodents. In: Vohora D (ed) Experimental and translational methods to screen drugs effective against seizures and epilepsy. Humana, New York, pp 79\u2013102"},{"key":"4766_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/3570549","volume":"7","author":"AW Kimball","year":"1957","unstructured":"Kimball AW, Burnett WT Jr, Doherty DG (1957) Chemical protection against ionizing radiation. I. Sampling methods for screening compounds in radiation protection studies with mice. Radiat Res 7:1\u201312","journal-title":"Radiat Res"},{"key":"4766_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12640-018-9876-4","volume":"34","author":"K Soca\u0142a","year":"2018","unstructured":"Soca\u0142a K, Nieoczym D, Pier\u00f3g M, Wyska E, Szafarz M, Doboszewska U, Wla\u017a P (2018) Effect of tadalafil on seizure threshold and activity of antiepileptic drugs in three acute seizure tests in mice. Neurotox Res 34:333\u2013346","journal-title":"Neurotox Res"},{"key":"4766_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-1-0716-1254-5_9","volume-title":"Experimental and translational methods to screen drugs effective against seizures and epilepsy","author":"R Khanam","year":"2021","unstructured":"Khanam R, Vohora D (2021) Protocol for 6 Hz corneal stimulation in rodents for refractory seizures. In: Vohora D (ed) Experimental and translational methods to screen drugs effective against seizures and epilepsy. Humana, New York, pp 167\u2013179"},{"key":"4766_CR41","doi-asserted-by":"publisher","first-page":"RC79","DOI":"10.1523\/JNEUROSCI.20-11-j0003.2000","volume":"20","author":"JY Lee","year":"2000","unstructured":"Lee JY, Cole TB, Palmiter RD, Koh JY (2000) Accumulation of zinc in degenerating hippocampal neurons of ZnT3-null mice after seizures: evidence against synaptic vesicle origin. J Neurosci 20:RC79","journal-title":"J Neurosci"},{"key":"4766_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eplepsyres.2018.04.004","volume":"143","author":"R Iqbal","year":"2018","unstructured":"Iqbal R, Jain GK, Siraj F, Vohora D (2018) Aromatase inhibition by letrozole attenuates kainic acid-induced seizures but not neurotoxicity in mice. Epilepsy Res 143:60\u201369","journal-title":"Epilepsy Res"},{"key":"4766_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0920-1211(99)00121-7","volume":"39","author":"TB Cole","year":"2000","unstructured":"Cole TB, Robbins CA, Wenzel HJ, Schwartzkroin PA, Palmiter RD (2000) Seizures and neuronal damage in mice lacking vesicular zinc. Epilepsy Res 39:153\u2013169","journal-title":"Epilepsy Res"},{"key":"4766_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-1-0716-1254-5_6","volume-title":"Experimental and translational methods to screen drugs effective against seizures and epilepsy","author":"H Potschka","year":"2021","unstructured":"Potschka H (2021) Procedures for electrical and chemical kindling models in rats and mice. In: Vohora D (ed) Experimental and translational methods to screen drugs effective against seizures and epilepsy. Humana, New York, pp 103\u2013119"},{"key":"4766_CR45","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1021\/acschemneuro.8b00476","volume":"10","author":"K Soca\u0142a","year":"2019","unstructured":"Soca\u0142a K, Mogilski S, Pier\u00f3g M, Nieoczym D, Abram M, Szulczyk B, Lubelska A, Latacz G, Doboszewska U, Wla\u017a P, Kami\u0144ski K (2019) KA-11, a novel pyrrolidine-2,5-dione derived broad-spectrum anticonvulsant: its antiepileptogenic, antinociceptive properties and in vitro characterization. ACS Chem Neurosci 10:636\u2013648","journal-title":"ACS Chem Neurosci"},{"key":"4766_CR46","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/molecules25051204","volume":"25","author":"K Soca\u0142a","year":"2020","unstructured":"Soca\u0142a K, Doboszewska U, Wla\u017a P (2020) Salvinorin A does not affect seizure threshold in mice. Molecules 25:1204","journal-title":"Molecules"},{"key":"4766_CR47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nrn3241","volume":"13","author":"G Buzsaki","year":"2012","unstructured":"Buzsaki G, Anastassiou CA, Koch C (2012) The origin of extracellular fields and currents\u2014EEG, ECoG, LFP and spikes. Nat Rev Neurosci 13:407\u2013420","journal-title":"Nat Rev Neurosci"},{"key":"4766_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2020.06.010","volume":"116","author":"K Gawel","year":"2020","unstructured":"Gawel K, Langlois M, Martins T, van der Ent W, Tiraboschi E, Jacmin M, Crawford AD, Esguerra CV (2020) Seizing the moment: zebrafish epilepsy models. Neurosci Biobehav Rev 116:1\u201320","journal-title":"Neurosci Biobehav Rev"},{"key":"4766_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054166","volume":"8","author":"T Afrikanova","year":"2013","unstructured":"Afrikanova T, Serruys AS, Buenafe OE, Clinckers R, Smolders I, de Witte PA, Crawford AD, Esguerra CV (2013) Validation of the zebrafish pentylenetetrazol seizure model: locomotor versus electrographic responses to antiepileptic drugs. PLoS ONE 8:e54166","journal-title":"PLoS ONE"},{"key":"4766_CR50","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1007\/s12035-019-01860-x","volume":"57","author":"K Gawel","year":"2020","unstructured":"Gawel K, Turski WA, van der Ent W, Mathai BJ, Kirstein-Smardzewska KJ, Simonsen A, Esguerra CV (2020) Phenotypic characterization of larval zebrafish (Danio rerio) with partial knockdown of the cacna1a gene. Mol Neurobiol 57:1904\u20131916","journal-title":"Mol Neurobiol"},{"key":"4766_CR51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1750-1326-6-65","volume":"6","author":"AM Grabrucker","year":"2011","unstructured":"Grabrucker AM, Schmeisser MJ, Udvardi PT, Arons M, Schoen M, Woodling NS, Andreasson KI, Hof PR, Buxbaum JD, Garner CC, Boeckers TM (2011) Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2\/Shank3 scaffold. Mol Neurodegener 6:65","journal-title":"Mol Neurodegener"},{"key":"4766_CR52","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","volume":"20","author":"W L\u00f6scher","year":"2011","unstructured":"L\u00f6scher W (2011) Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 20:359\u2013368","journal-title":"Seizure"},{"key":"4766_CR53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.omtm.2020.06.006","volume":"18","author":"Y Ilan","year":"2020","unstructured":"Ilan Y (2020) Overcoming compensatory mechanisms toward chronic drug administration to ensure long-term, sustainable beneficial effects. Mol Ther Methods Clin Dev 18:335\u2013344","journal-title":"Mol Ther Methods Clin Dev"},{"key":"4766_CR54","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/nan.12150","volume":"40","author":"M Thom","year":"2014","unstructured":"Thom M (2014) Review: hippocampal sclerosis in epilepsy: a neuropathology review. Neuropathol Appl Neurobiol 40:520\u2013543","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4766_CR55","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0006-8993(85)91612-9","volume":"337","author":"J P\u00e9rez-Clausell","year":"1985","unstructured":"P\u00e9rez-Clausell J, Danscher G (1985) Intravesicular localization of zinc in rat telencephalic boutons. A histochemical study. Brain Res 337:91\u201398","journal-title":"Brain Res"},{"key":"4766_CR56","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1039\/C4MT00230J","volume":"7","author":"W Maret","year":"2015","unstructured":"Maret W (2015) Analyzing free zinc(II) ion concentrations in cell biology with fluorescent chelating molecules. Metallomics 7:202\u2013211","journal-title":"Metallomics"},{"key":"4766_CR57","doi-asserted-by":"publisher","first-page":"8688","DOI":"10.1038\/ncomms9688","volume":"6","author":"KM van Loo","year":"2015","unstructured":"van Loo KM, Schaub C, Pitsch J, Kulbida R, Opitz T, Ekstein D, Dalal A, Urbach H, Beck H, Yaari Y, Schoch S, Becker AJ (2015) Zinc regulates a key transcriptional pathway for epileptogenesis via metal-regulatory transcription factor 1. Nat Commun 6:8688","journal-title":"Nat Commun"},{"key":"4766_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2020.126499","volume":"60","author":"C Scassellati","year":"2020","unstructured":"Scassellati C, Bonvicini C, Benussi L, Ghidoni R, Squitti R (2020) Neurodevelopmental disorders: metallomics studies for the identification of potential biomarkers associated to diagnosis and treatment. J Trace Elem Med Biol 60:126499","journal-title":"J Trace Elem Med Biol"},{"key":"4766_CR59","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.3390\/ijms20164006","volume":"20","author":"W Alker","year":"2019","unstructured":"Alker W, Schwerdtle T, Schomburg L, Haase H (2019) A zinpyr-1-based fluorimetric microassay for free zinc in human serum. Int J Mol Sci 20:4006","journal-title":"Int J Mol Sci"},{"key":"4766_CR60","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1042\/EBC20160069","volume":"61","author":"MC Carpenter","year":"2017","unstructured":"Carpenter MC, Palmer AE (2017) Native and engineered sensors for Ca2+ and Zn2+: lessons from calmodulin and MTF1. Essays Biochem 61:237\u2013243","journal-title":"Essays Biochem"},{"key":"4766_CR61","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677\u2013736","journal-title":"Annu Rev Neurosci"},{"key":"4766_CR62","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jad.2020.03.137","volume":"272","author":"F Mo","year":"2020","unstructured":"Mo F, Tang Y, Du P, Shen Z, Yang J, Cai M, Zhang Y, Li H, Shen H (2020) GPR39 protects against corticosterone-induced neuronal injury in hippocampal cells through the CREB-BDNF signaling pathway. J Affect Disord 272:474\u2013484","journal-title":"J Affect Disord"},{"key":"4766_CR63","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jad.2016.05.007","volume":"201","author":"K M\u0142yniec","year":"2016","unstructured":"M\u0142yniec K, Starowicz G, Gawe\u0142 M, Fr\u0105ckiewicz E, Nowak G (2016) Potential antidepressant-like properties of the TC G-1008, a GPR39 (zinc receptor) agonist. J Affect Disord 201:179\u2013184","journal-title":"J Affect Disord"},{"key":"4766_CR64","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.tips.2006.10.002","volume":"27","author":"M Simonato","year":"2006","unstructured":"Simonato M, Tongiorgi E, Kokaia M (2006) Angels and demons: neurotrophic factors and epilepsy. Trends Pharmacol Sci 27:631\u2013638","journal-title":"Trends Pharmacol Sci"},{"key":"4766_CR65","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1523\/JNEUROSCI.5093-08.2009","volume":"29","author":"L Besser","year":"2009","unstructured":"Besser L, Chorin E, Sekler I, Silverman WF, Atkin S, Russell JT, Hershfinkel M (2009) Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus. J Neurosci 29:2890\u20132901","journal-title":"J Neurosci"},{"key":"4766_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110160","volume":"127","author":"W Satianrapapong","year":"2020","unstructured":"Satianrapapong W, Pongkorpsakol P, Muanprasat C (2020) A G-protein coupled receptor 39 agonist stimulates proliferation of keratinocytes via an ERK-dependent pathway. Biomed Pharmacother 127:110160","journal-title":"Biomed Pharmacother"},{"key":"4766_CR67","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1503\/jpn.200149","volume":"45","author":"PR Albert","year":"2020","unstructured":"Albert PR (2020) Orphans to the rescue: orphan G-protein coupled receptors as new antidepressant targets. J Psychiatry Neurosci 45:301\u2013303","journal-title":"J Psychiatry Neurosci"},{"key":"4766_CR68","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.tins.2017.06.008","volume":"40","author":"YE Moore","year":"2017","unstructured":"Moore YE, Kelley MR, Brandon NJ, Deeb TZ, Moss SJ (2017) Seizing control of KCC2: a new therapeutic target for epilepsy. Trends Neurosci 40:555\u2013571","journal-title":"Trends Neurosci"},{"key":"4766_CR69","doi-asserted-by":"publisher","first-page":"9259","DOI":"10.1523\/JNEUROSCI.0237-13.2013","volume":"33","author":"T Perez-Rosello","year":"2013","unstructured":"Perez-Rosello T, Anderson CT, Schopfer FJ, Zhao Y, Gilad D, Salvatore SR, Freeman BA, Hershfinkel M, Aizenman E, Tzounopoulos T (2013) Synaptic Zn2+ inhibits neurotransmitter release by promoting endocannabinoid synthesis. J Neurosci 33:9259\u20139272","journal-title":"J Neurosci"},{"key":"4766_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101207","volume":"49","author":"KV Grunddal","year":"2021","unstructured":"Grunddal KV, Diep TA, Petersen N, Tough IR, Skov LJ, Liu L, Buijink JA, Mende F, Jin C, Jepsen SL, S\u00f8rensen LME, Achiam MP, Strandby RB, Bach A, Hartmann B, Frimurer TM, Hjorth SA, Bouvier M, Cox H, Holst B (2021) Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist. Mol Metab 49:101207","journal-title":"Mol Metab"},{"key":"4766_CR71","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1021\/acs.jmedchem.6b00648","volume":"60","author":"TM Frimurer","year":"2017","unstructured":"Frimurer TM, Mende F, Graae AS, Engelstoft MS, Egerod KL, Nygaard R, Gerlach LO, Hansen JB, Schwartz TW, Holst B (2017) Model-based discovery of synthetic agonists for the Zn2+-sensing G-protein-coupled receptor 39 (GPR39) reveals novel biological functions. J Med Chem 60:886\u2013898","journal-title":"J Med Chem"},{"key":"4766_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145849","volume":"10","author":"O Fjellstr\u00f6m","year":"2015","unstructured":"Fjellstr\u00f6m O, Larsson N, Yasuda S, Tsuchida T, Oguma T, Marley A, Wennberg-Huldt C, Hovdal D, Fukuda H, Yoneyama Y, Sasaki K, Johansson A, Lundqvist S, Brengdahl J, Isaacs RJ, Brown D, Geschwindner S, Benthem L, Priest C, Turnbull A (2015) Novel Zn2+ modulated GPR39 receptor agonists do not drive acute insulin secretion in rodents. PLoS ONE 10:e0145849","journal-title":"PLoS ONE"},{"key":"4766_CR73","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nchembio.1481","volume":"10","author":"F Bassilana","year":"2014","unstructured":"Bassilana F, Carlson A, DaSilva JA, Grosshans B, Vidal S, Beck V, Wilmeringwetter B, Llamas LA, Showalter TB, Rigollier P, Bourret A, Ramamurthy A, Wu X, Harbinski F, Plonsky S, Lee L, Ruffner H, Grandi P, Schirle M, Jenkins J, Sailer AW, Bouwmeester T, Porter JA, Myer V, Finan PM, Tallarico JA, Kelleher JF III, Seuwen K, Jain RK, Luchansky SJ (2014) Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39. Nat Chem Biol 10:343\u2013349","journal-title":"Nat Chem Biol"},{"key":"4766_CR74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2122512119","volume":"119","author":"Y Li","year":"2022","unstructured":"Li Y, Wei L, Meinsohn MC, Suliman R, Chauvin M, Berstler J, Hartland K, Jensen MM, Sicher NA, Nagykery N, Donahoe PK, Pepin D (2022) A screen of repurposed drugs identifies AMHR2\/MISR2 agonists as potential contraceptives. Proc Natl Acad Sci USA 119:e2122512119","journal-title":"Proc Natl Acad Sci USA"},{"key":"4766_CR75","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/15257770.2021.2002892","volume":"41","author":"JR Gutierr\u00e9z-Ruiz","year":"2022","unstructured":"Gutierr\u00e9z-Ruiz JR, Villafa\u00f1a S, Ruiz-Hern\u00e1ndez A, Viruette-Pontigo D, Menchaca-Cervantes C, Aguayo-Cer\u00f3n KA, Huang F, Hong E, Romero-Nava R (2022) Expression profiles of GPR21, GPR39, GPR135, and GPR153 orphan receptors in different cancers. Nucleosides Nucleotides Nucleic Acids 41:123\u2013136","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"4766_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2011.09.005","volume":"97","author":"PE Schauwecker","year":"2011","unstructured":"Schauwecker PE (2011) The relevance of individual genetic background and its role in animal models of epilepsy. Epilepsy Res 97:1\u201311","journal-title":"Epilepsy Res"},{"key":"4766_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107842","volume":"225","author":"K Mlyniec","year":"2021","unstructured":"M\u0142yniec K, Siod\u0142ak D, Doboszewska U, Nowak G (2021) GPCR oligomerization as a target for antidepressants: focus on GPR39. Pharmacol Ther 225:107842","journal-title":"Pharmacol Ther"},{"key":"4766_CR78","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1016\/j.bbadis.2015.09.003","volume":"1852","author":"M Tena-Campos","year":"2015","unstructured":"Tena-Campos M, Ramon E, Borroto-Escuela DO, Fuxe K, Garriga P (2015) The zinc binding receptor GPR39 interacts with 5-HT1A and GalR1 to form dynamic heteroreceptor complexes with signaling diversity. Biochim Biophys Acta 1852:2585\u20132592","journal-title":"Biochim Biophys Acta"},{"key":"4766_CR79","doi-asserted-by":"publisher","first-page":"14214","DOI":"10.1074\/jbc.271.24.14214","volume":"271","author":"AN Moore","year":"1996","unstructured":"Moore AN, Waxham MN, Dash PK (1996) Neuronal activity increases the phosphorylation of the transcription factor cAMP response element-binding protein (CREB) in rat hippocampus and cortex. J Biol Chem 271:14214\u201314220","journal-title":"J Biol Chem"},{"key":"4766_CR80","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jad.2018.11.003","volume":"245","author":"G Starowicz","year":"2019","unstructured":"Starowicz G, Jarosz M, Fr\u0105ckiewicz E, Grzechnik N, Ostachowicz B, Nowak G, M\u0142yniec K (2019) Long-lasting antidepressant-like activity of the GPR39 zinc receptor agonist TC-G 1008. J Affect Disord 245:325\u2013334","journal-title":"J Affect Disord"},{"key":"4766_CR81","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nn.2316","volume":"12","author":"M Hershfinkel","year":"2009","unstructured":"Hershfinkel M, Kandler K, Knoch ME, Dagan-Rabin M, Aras MA, Abramovitch-Dahan C, Sekler I, Aizenman E (2009) Intracellular zinc inhibits KCC2 transporter activity. Nat Neurosci 12:725\u2013727","journal-title":"Nat Neurosci"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-04766-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-023-04766-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-04766-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T06:15:26Z","timestamp":1684304126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-023-04766-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["4766"],"URL":"https:\/\/doi.org\/10.1007\/s00018-023-04766-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1182423\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-1182423\/v2","asserted-by":"object"}]},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"3 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Housing and experimental procedures were conducted in accordance with the European Union Directive of 22 September 2010 (2010\/63\/EU) and Polish and Norwegian legislation acts concerning animal experimentation. The experiments in mice were approved by the Local Ethics Committee in Lublin (experiments in non-genetically modified mice: approval numbers 38\/2017, 48\/2018, 110\/2018, 36\/2019; experiments in GPR39 KO mice: approval numbers 72\/2019, 16\/2020), and the I Local Ethics Committee in Warsaw (approval number 811\/2019 regarding generation of the GPR39 KO mouse line). The experiments in zebrafish were approved by the Norwegian Food Safety Authority experimental animal administration's supervisory and application system (\u201cFors\u00f8ksdyrforvaltningen tilsyns- og s\u00f8knadssystem\u201d; FOTS ID 15469 and 23935).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"133"}}